• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

byJayden BerdugoandAlex Chan
July 2, 2025
in Chronic Disease, Neurology, Oncology, Pediatrics Classics, Restricted
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this retrospective cohort study, breast cancer survivors had a lower risk of Alzheimer’s dementia compared with cancer-free controls. 

2. Radiation therapy was associated with a significantly decreased risk of AD development among breast cancer survivors. 

Evidence Rating Level: 2 (Good)

Breast cancer is the most common cancer affecting women worldwide, with advances in treatment increasing survival rates to above 93% for early-stage disease. With this increase in survival, there has been an emerging focus on quality of life and long-term health consequences, including cognitive decline. Many survivors have reported cognitive difficulties; however, the relationship between breast cancer and Alzheimer’s disease (AD) remains unclear. To address this knowledge gap, this retrospective cohort study used a Korean national database to examine the association between breast cancer, its treatment and AD risk. The main outcome of this study was the development of a new AD diagnosis, defined as having at least one prescription for antidementia medications during the follow-up period. Among the cohort of 70,701 breast cancer survivors (mean [SD] age, 53.1 [8.5] years), 1,229 individuals were diagnosed with AD, corresponding to an incidence rate of 2.45 per 1,000 person years. During follow-up, there were 1,229 new cases among breast cancer survivors (incidence rate 2.45 per 1000 person-years), and 3430 new cases among cancer-free controls (incidence rate 2.63 per 1000 person-years). There was a lower risk of AD among the survivors than the controls (SHR, 0.92; 95% CI, 0.85-0.99); however, this decreased risk did not persist past 5 years. Radiation therapy was associated with the lowest risk of AD development (AHR, 0.77; 95% CI, 0.68-0.87) compared with other treatment modalities. In summary, this cohort of breast cancer survivors had a slightly lower risk of AD incidence compared to their respective cancer-free controls. The results of this study suggest that certain cancer treatments may be protective for AD, however, further research in this area is needed. 

Click to read the study in JAMA Network Open

Image: PD

RELATED REPORTS

AstraZeneca moves to own multimodal oncology AI with Modella

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: alzheimer's dementiaBreast Cancerdementiageriatric medicineoncology
Previous Post

Evaluating scar outcomes in pediatric burn patients following skin grafting 

Next Post

Weighted vests and resistance training confer similar outcomes for bone density in the elderly

RelatedReports

Patients with advanced adenomas are at increased risk of developing colorectal cancer
AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Cardiology

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

January 12, 2026
Chronic Disease

High-flow nasal therapy with room air and fan therapy provide modest relief of dyspnea in advanced cancer patients who are not hypoxemic

January 12, 2026
Next Post

Weighted vests and resistance training confer similar outcomes for bone density in the elderly

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

2 Minute Medicine Rewind June 30, 2025

Reduced gestational weight gain with lifestyle intervention

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Duloxetine is effective in refractory chronic cough
  • AstraZeneca moves to own multimodal oncology AI with Modella
  • Cast immobilization is non-inferior to surgical intervention in isolated Weber B fractures of lateral malleolus
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.